The development of cytotoxic drugs involves rigorous research and testing to ensure efficacy and safety. Preclinical studies on cell cultures and animals precede clinical trials in humans. Regulatory agencies, such as the U.S. Food and Drug Administration (FDA), evaluate the data before approving these drugs for clinical use.
